10395 - Aprocitentan for treating resistant hypertension TS ID 10395Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Alcohol-mediated perivascular renal sympathetic denervation for resistant hypertensionStatus:In developmentProgramme:Interventional procedures guidanceExpected publication date: 5 February 2025
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (IPG554)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 April 2016
Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertensionStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Hypertension in adults (QS28)Product type:Quality standardLast updated: 1 September 2015Published: 20 March 2013
Hypertension in adults: diagnosis and management (NG136)Product type:GuidanceProgramme:NICE guidelineLast updated: 21 November 2023Published: 28 August 2019
Hypertension in pregnancy (QS35)Product type:Quality standardLast updated: 23 July 2019Published: 16 July 2013
Hypertension in pregnancy: diagnosis and management (NG133)Product type:GuidanceProgramme:NICE guidelineLast updated: 17 April 2023Published: 25 June 2019
Implanting a baroreceptor stimulation device for resistant hypertension (IPG533)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 October 2015
Inhaled treprostinil for treating pulmonary hypertension caused by interstitial lung disease ID6459Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Macitentan for treating pulmonary arterial hypertension in people 1 month to 17 years TS ID 11805Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Macitentant–tadalafil for treating pulmonary arterial hypertension TS ID 10517Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Percutaneous transluminal renal sympathetic denervation for resistant hypertension (IPG754)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 1 March 2023
Secondary care management of malignant hypertensionStatus:Awaiting developmentExpected publication date: TBC
Sotatercept for treating pulmonary arterial hypertension [ID6163]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 15 October 2025
Telemetric adjustable pulmonary artery banding for pulmonary hypertension in infants with congenital heart defects (IPG505)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 November 2014
Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Treprostinil diethanolamine for treating pulmonary arterial hypertension TS ID 11772Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Treprostinil for treating symptomatic chronic thromboembolic pulmonary hypertension [ID3926 ]Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC